Učitavanje...

Feasibility of Treating Adults with Ewing or Ewing‐Like Sarcoma with Interval‐Compressed Vincristine, Doxorubicin, and Cyclophosphamide Alternating with Ifosfamide and Etoposide

BACKGROUND: Vincristine, doxorubicin, and cyclophosphamide (VDC) alternating with ifosfamide and etoposide (IE) administered every 2 weeks demonstrated a superior event‐free survival compared with 3‐week dosing in a landmark pediatric trial and is now standard of care for younger patients. Only 12%...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncologist
Glavni autori: Lu, Eric, Ryan, Christopher W., Bassale, Solange, Lim, Jeong Youn, Davis, Lara E.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Inc. 2019
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7011630/
https://ncbi.nlm.nih.gov/pubmed/32043790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0532
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!